Apoptosis induction of human leukemia U937 cells by 7,8-dihydroxyflavone hydrate through modulation of the Bcl-2 family of proteins and the MAPKs signaling pathway

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 751, Issue 2, 2013, Pages 101-108

  Park, Hye Young ^a   Kim, Gi Young ^b   Kwon, Taeg Kyu ^c   Hwang, Hye Jin ^d   Kim, Nam Deuk ^a   Yoo, Young Hyun ^e   Choi, Yung Hyun ^d  

^a Pusan National University   (South Korea)

^b Jeju National University   (South Korea)

^c Keimyung University   (South Korea)

^d Dong Eui University   (South Korea)

^e Dong A University   (South Korea)

Author keywords

7,8 Dihydroxyflavone hydrate; Apoptosis; Bcl 2; MAPKs; U937 cells

Indexed keywords

7,8 DIHYDROXYFLAVONE; CASPASE; DEATH RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

APOPTOSIS; ARTICLE; CELL STRAIN U937; DNA FRAGMENTATION; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; UPREGULATION;

APOPTOSIS; CASPASES; CELL PROLIFERATION; CYTOCHROMES C; FLAVONES; HUMANS; LEUKEMIA; MAP KINASE SIGNALING SYSTEM; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, TRKB; RECEPTORS, DEATH DOMAIN; SIGNAL TRANSDUCTION; U937 CELLS;

EID: 84874229489     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2012.12.002     Document Type: Article

References (41)

1. Jin Z., El-Deiry W.S. Overview of cell death signaling pathways. Cancer Biol. Ther. 2005, 4:139-163.
2. Fulda S., Debatin K.M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006, 25:4798-4811.
3. Ashkenazi A. Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev. 2008, 19:325-331.
4. Röder C., Trauzold A., Kalthoff H. Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma. Eur. J. Cell Biol. 2011, 90:450-455.
5. Shamas-Din A., Brahmbhatt H., Leber B., Andrews D.W. BH3-only proteins: orchestrators of apoptosis. Biochim. Biophys. Acta 2011, 1813:508-520.
6. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., Earnshaw W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371:346-347.
7. Fukuda K. Apoptosis-associated cleavage of β-catenin in human colon cancer and rat hepatoma cells. Int. J. Biochem. Cell Biol. 1999, 31:519-529.
8. Brenner D., Mak T.W. Mitochondrial cell death effectors. Curr. Opin. Cell Biol. 2009, 21:871-877.
9. Caroppi P., Sinibaldi F., Fiorucci L., Santucci R. Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome c as proapoptotic protein. Curr. Med. Chem. 2009, 16:4058-4065.
10. Ola M.S., Nawaz M., Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol. Cell. Biochem. 2011, 351:41-58.
11. Danson S., Dean E., Dive C., Ranson M. IAPs as a target for anticancer therapy. Curr. Cancer Drug Targets 2007, 7:785-794.
12. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270:1326-1331.
13. Boutros T., Chevet E., Metrakos P. Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol. Rev. 2008, 60:261-310.
14. Panka D.J., Atkins M.B., Mier J.W. Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma. Clin. Cancer Res. 2006, 12:2371-2375.
15. Plotnikov A., Zehorai E., Procaccia S., Seger R. The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim. Biophys. Acta 2011, 1813:1619-1633.
16. Wagner E.F., Nebreda A.R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 2009, 9:537-549.
17. Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 1998, 56:317-333.
18. Birt D.F., Hendrich S., Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther. 2001, 90:157-177.
19. Chahar M.K., Sharma N., Dobhal M.P., Joshi Y.C. Flavonoids A versatile source of anticancer drugs. Pharmacogn. Rev. 2011, 5:1-12.
20. Galati G., Teng S., Moridani M.Y., Chan T.S., O'Brien P.J. Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics. Drug Metab. Drug Interact. 2000, 17:311-349.
21. Yang C.S., Landau J.M., Huang M.T., Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 2001, 21:381-406.
22. Huang W.Y., Cai Y.Z., Zhang Y. Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr. Cancer 2010, 62:1-20.
23. Kilani-Jaziri S., Frachet V., Bhouri W., Ghedira K., Chekir-Ghedira L., Ronot X. Flavones inhibit the proliferation of human tumor cancer cell lines by inducing apoptosis. Drug Chem. Toxicol. 2012, 35:1-10.
24. Manthey J.A., Grohmann K., Guthrie N. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr. Med. Chem. 2001, 8:135-153.
25. Newcomb E.W. Flavopiridol: pleiotropic biological effects enhance its anti-cancer activity. Anticancer Drugs 2004, 15:411-419.
26. Moon Y.J., Wang X., Morris M.E. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol. In Vitro 2006, 20:187-210.
27. Verschoyle R.D., Steward W.P., Gescher A.J. Putative cancer chemopreventive agents of dietary origin-how safe are they?. Nutr. Cancer 2007, 59:152-162.
28. Jang S.W., Liu X., Yepes M., Shepherd K.R., Miller G.W., Liu Y., Wilson W.D., Xiao G., Blanchi B., Sun Y.E., Ye K. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:2687-2692.
29. Andero R., Heldt S.A., Ye K., Liu X., Armario A., Ressler K.J. Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am. J. Psychiatry 2011, 168:163-172.
30. Chen J., Chua K.W., Chua C.C., Yu H., Pei A., Chua B.H., Hamdy R.C., Xu X., Liu C.F. Antioxidant activity of 7,8-dihydroxyflavone provides neuroprotection against glutamate-induced toxicity. Neurosci. Lett. 2011, 499:181-185.
31. Johnson R.A., Lam M., Punzo A.M., Li H., Lin B.R., Ye K., Mitchell G.S., Chang Q. 7,8-Dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome. J. Appl. Physiol. 2012, 112:704-710.
32. Devi L., Ohno M. 7,8-Dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Neuropsychopharmacology 2012, 37:434-444.
33. Kozics K., Valovicova Z., Slamenova D. Structure of flavonoids influences the degree inhibition of Benzo(a)pyrene-induced DNA damage and micronuclei in HepG2 cells. Neoplasma 2011, 58:516-524.
34. Park H.Y., Kim G.Y., Hyun J.W., Hwang H.J., Kim H.J.N.D., Kim B.W., Choi Y.H. 7,8-Dihydroxyflavone exhibits anti-inflammatory properties by down-regulating NF-κB and MAPKS signaling pathways in lipopolysaccharide-treated RAW264.7 cells. Int. J. Mol. Med. 2012, 29:1146-1152.
35. Zhang R., Kang K.A., Piao M.J., Ko D.O., Wang Z.H., Chang W.Y., You H.J., Lee I.K., Kim B.J., Kang S.S., Hyun J.W. Preventive effect of 7,8-dihydroxyflavone against oxidative stress induced genotoxicity. Biol. Pharm. Bull. 2009, 32:166-171.
36. Park H.Y., Kim G.Y., Hyun J.W., Kim N.D., Kim C.G., Kim W.J., Yoo Y.H., Choi Y.H. 7,8-Dihydroxyflavone induces G1 arrest of the cell cycle in U937 human monocytic leukemia cells via induction of the Cdk inhibitor p27 and downregulation of pRB phosphorylation. Oncol. Rep. 2012, 28:353-357.
37. Kim S.Y., Kang H.T., Choi H.R., Park S.C. Biliverdin reductase A in the prevention of cellular senescence against oxidative stress. Exp. Mol. Med. 2011, 43:15-23.
38. Jin Y.C., Han J.A., Xu C.X., Kang S.K., Kim S.H., Seo K.S., Yoon D.H., Choi Y.J., Lee H.G. Functional study of Villin 2 protein expressed in longissimus dorsi muscle of Korean native cattle in different growth stages. BMB Rep. 2012, 45:102-107.
39. Hermine O., Haioun C., Lepage E., D'Agay M.-F., Briere J., Lavignac C., Fillet G., Salles G., Marolleau J.-P., Diebold J., Reyes F., Gaulard P. Prognostic significance of bcl-2 protein expression in aggressive Non-Hodgkin's Lymphoma. Blood 1996, 87:265-272.
40. Eskes R., Desagher S., Antonsson B., Martinou J.C. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 2000, 20:929-935.
41. Nechushtan A., Smith C.L., Hsu Y.T., Youle R.J. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J. 1999, 18:2330-2341.